Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial A range of zero to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback